![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Parotid Diseases - 25 Studies Found
Completed |
: Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Parotidectomy Surgery : Parotid Diseases : 2014-11-04 : Procedure: Parotidectomy Surgical Intervention with the FMwand Surgical System |
Not yet recruiting |
: Gender and Opioid Consumption : Postoperative; Parotitis : 2016-12-27 : Drug: postoperative morphine Postoperatively, A loading dose of morphine will be given in incremental do |
Recruiting |
: SPI-directed Analgesia for Vitreoretinal Surgeries :
|
Not yet recruiting |
: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants : Epidemic Parotitis,Mumps : 2017-04-17 :
|
Recruiting |
: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine :
|
Active, not recruiting |
: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants : Mumps : 2016-02-23 :
|
Completed |
: Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors :
: 2015-08-17 : Behavioral: Facial exercises A series of self-administered facial movements and expressions. |
Active, not recruiting |
: Feasibility Study of MRI Imaging on Parotid Gland Stimulation : Parotid Neoplasms : 2014-11-12 :
|
Completed |
: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age : Measles; Mumps; Rubella : 2014-07-03 :
|
Completed |
: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older :
: 2014-02-06 :
|